Plus a lot more: data on launch price media coverage, CVS/Humira moves, a deep dive on Jan. 1 prices ...
And why 2024 will be the year of the launch price
Plus, in a twist on a Jan. 1 tradition, there's lot of attention on drug price *decreases*
And the Jan. 1 price-increase stories are starting to roll in
So keep those votes coming in ...
But the competition only gets more fierce from here on out, and we need your votes
Plus a handful of additional items that found their way under the tree
And, yes, there's still news, including deep looks at IRA incentives and priority review vouchers
And teasing that we're going to lay out the rules for Cost Curve Fight Club tomorrow
And the holiday slowdown doesn't seem to have kicked in yet ...
A great take on the IRA: "I guess you negotiate with a mugger when they show up. It's your money or your life."
And Public Citizen goes all-in on exploring industry-advocacy ties in a way that makes me nervous
